After his retirement in 2011, Mendelsohn remained on the faculty as co-director of the new Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy. He was a senior fellow in health and technology at the Baker Institute. Mendelsohn was only the third full-time president of MD Anderson.